STOCK MARKET BSE NSE

Can Aspirin Help Stop Dementia Too?

Aspirin is generally known to be useful in preventing heart attacks and strokes, but now researchers believe the humble aspirin could also hold the key to warding off dementia and cancer.

Published: 02nd December 2013 02:30 PM  |   Last Updated: 02nd December 2013 02:30 PM   |  A+A-

Regular_strength_enteric_coated_aspirin_tablets
By IANS

Aspirin is generally known to be useful in preventing heart attacks and strokes, but now researchers believe the humble aspirin could also hold the key to warding off dementia and cancer.

The claim has been made at the launch of the largest ever study into the health benefits of the everyday medicine, which has long been thought of as a health-booster.

A study of 15,000 people aged over 70 will be the most extensive clinical trial on the use of aspirin to prevent disease in the elderly, Daily Mail reported.

Research team leader Mark Nelson, from Hobart’s Menzies Research Institute in Tasmania, Australia, said: "Remember aspirin is an over-the-counter medication; you don’t need a doctor to prescribe it, you don’t need a doctor to tell you you've turned 70. So this is something that can be done very simply, very cheaply if we find that it’s an effective strategy."

Nelson said the study starts next summer and results are expected in 2018.

Millions of people who take the pill to fight heart disease or the risk of a stroke benefit from its effectiveness at thinning the blood and how it helps to prevent clotting.

It cuts the danger of further heart attacks or strokes by at least 23 per cent.

Research has shown regular users have a lower risk of developing Alzheimer’s disease, the main form of dementia.

Scientists believe its protective effect may be due to its anti-clotting action helping blood flow to the brain.

Research has also shown that aspirin may have a role in fighting cancer, particularly gastro-intestinal cancers.

"Now that makes sense because you take it orally so in aspirin you’ve got that natural component."

In the study - in the journal Contemporary Clinical Trials - the team wants to establish whether the benefits of a low dose of aspirin outweigh the risks linked to its use.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp